ivabradine has been researched along with bradykinin in 1 studies
| Studies (ivabradine) | Trials (ivabradine) | Recent Studies (post-2010) (ivabradine) | Studies (bradykinin) | Trials (bradykinin) | Recent Studies (post-2010) (bradykinin) |
|---|---|---|---|---|---|
| 1,143 | 197 | 833 | 14,195 | 355 | 1,520 |
| Protein | Taxonomy | ivabradine (IC50) | bradykinin (IC50) |
|---|---|---|---|
| B2 bradykinin receptor | Homo sapiens (human) | 0.0018 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campanelli, JJ; Christensen, LP; Dedkov, EI; Tomanek, RJ; Weiss, RM; Zhang, RL; Zheng, W | 1 |
1 other study(ies) available for ivabradine and bradykinin
| Article | Year |
|---|---|
Postmyocardial infarction remodeling and coronary reserve: effects of ivabradine and beta blockade therapy.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Animals; Atenolol; Benzazepines; Bradykinin; Cardiotonic Agents; Collagen; Coronary Circulation; Electrocardiography; Heart Rate; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Ivabradine; Male; Myocardial Infarction; Neovascularization, Physiologic; Organ Size; Perfusion; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Ventricular Remodeling | 2009 |